The Drug Industry Is Working Hard To Get This Alzheimer’s Drug Approved, And The Outcome Will Be Huge
In the next two months the Centers for Medicare and Medicaid Services (CMS) will decide if the questionable and very expensive drug Aduhelm for Alzheimer’s disease will get the government’s […]